Enpp-1-IN-23 (compound 27) is an Enpp-1 inhibitor, with IC50 of 1.2 nM. Enpp-1-IN-23 can be used in cancer research[1].
IC 50
Enpp-1: 1.2 nM (IC50)
References
[1] Gao S, et al. Discovery of orally bioavailable phosphonate prodrugs of potent ENPP1 inhibitors for cancer treatment. Eur J Med Chem. 2024 Sep 10;279:116853. DOI:10.1016/j.ejmech.2024.116853